{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T08:51:05Z","timestamp":1782118265978,"version":"3.54.5"},"reference-count":47,"publisher":"Pacini Editore","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Otorhinolaryngol Ital"],"DOI":"10.14639\/0392-100x-a1264","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T08:25:20Z","timestamp":1782116720000},"page":"161-171","source":"Crossref","is-referenced-by-count":0,"title":["Development of depression in patients with oropharyngeal cancer: a systematic review"],"prefix":"10.14639","volume":"46","author":[{"given":"Ida","family":"Salskov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla Juul","family":"Kibsgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda-Louise Fenger","family":"Carlander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Sofie","family":"Kvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrine Kronberg","family":"Jakobsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Gr\u00f8nh\u00f8j","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"von Buchwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"20340","published-online":{"date-parts":[[2026,6]]},"reference":[{"key":"10.14639\/0392-100X-A1264_ref1","doi-asserted-by":"crossref","unstructured":"Mehanna H, Taberna M, von Buchwald C, et al. Prognostic implications of p16 and HPV discordance in oropharyngeal cancer (HNCIG-EPIC-OPC): a multicentre, multinational, individual patient data analysis. Lancet Oncol 2023;24:239-251. https:\/\/doi.org\/10.1016\/S1470-2045(23)00013-X","DOI":"10.1016\/S1470-2045(23)00013-X"},{"key":"10.14639\/0392-100X-A1264_ref2","doi-asserted-by":"crossref","unstructured":"Ferlay J, Colombet M, Soerjomataram I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer 2019;144:1941-1953. httpss:\/\/doi.org\/10.1002\/ijc.31937","DOI":"10.1002\/ijc.31937"},{"key":"10.14639\/0392-100X-A1264_ref3","doi-asserted-by":"crossref","unstructured":"Carlander AF, Jakobsen KK, Bendtsen SK, et al. A contemporary systematic review on repartition of HPV-positivity in oropharyngeal cancer worldwide. Viruses 2021;13:1326. https:\/\/doi.org\/10.3390\/v13071326","DOI":"10.3390\/v13071326"},{"key":"10.14639\/0392-100X-A1264_ref4","doi-asserted-by":"crossref","unstructured":"Chaturvedi AK, Anderson WF, Lortet-Tieulent J, et al. Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Oncol 2013;31:4550-4559. https:\/\/doi.org\/10.1200\/JCO.2013.50.3870","DOI":"10.1200\/JCO.2013.50.3870"},{"key":"10.14639\/0392-100X-A1264_ref5","doi-asserted-by":"crossref","unstructured":"Hayes DN, Van Waes C, Seiwert TY. Genetic landscape of human papillomavirus-associated head and neck cancer and comparison to tobacco-related tumors. J Clin Oncol 2015;33:3227-3234. https:\/\/doi.org\/10.1200\/JCO.2015.62.1086","DOI":"10.1200\/JCO.2015.62.1086"},{"key":"10.14639\/0392-100X-A1264_ref6","doi-asserted-by":"crossref","unstructured":"Lewis JS, Khan RA, Masand RP, et al. Recognition of nonkeratinizing morphology in oropharyngeal squamous cell carcinoma \u2013 a prospective cohort and interobserver variability study. Histopathology 2012;60:427-436. https:\/\/doi.org\/10.1111\/j.1365-2559.2011.04092.x","DOI":"10.1111\/j.1365-2559.2011.04092.x"},{"key":"10.14639\/0392-100X-A1264_ref7","doi-asserted-by":"crossref","unstructured":"Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010;363:24-35. https:\/\/doi.org\/10.1056\/nejmoa0912217","DOI":"10.1056\/NEJMoa0912217"},{"key":"10.14639\/0392-100X-A1264_ref8","doi-asserted-by":"crossref","unstructured":"Larsen CG, Jensen DH, Carlander ALF, et al. Novel nomograms for survival and progression in HPV+ and HPV- oropharyngeal cancer: a population-based study of 1,542 consecutive patients. Oncotarget 2016;7:71761-71772. https:\/\/doi.org\/10.18632\/oncotarget.12335","DOI":"10.18632\/oncotarget.12335"},{"key":"10.14639\/0392-100X-A1264_ref9","doi-asserted-by":"crossref","unstructured":"Borras JM, Barton M, Grau C, et al. The impact of cancer incidence and stage on optimal utilization of radiotherapy: methodology of a population based analysis by the ESTRO-HERO project. Radiother Oncol 2015;116:45-50. https:\/\/doi.org\/10.1016\/j.radonc.2015.04.021","DOI":"10.1016\/j.radonc.2015.04.018"},{"key":"10.14639\/0392-100X-A1264_ref10","doi-asserted-by":"crossref","unstructured":"Machiels JP, Leemans RC, Golusinski W, et al. Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS\u2013ESMO\u2013ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2020;31:1462-1475. https:\/\/doi.org\/10.1016\/j.annonc.2020.07.011","DOI":"10.1016\/j.annonc.2020.07.011"},{"key":"10.14639\/0392-100X-A1264_ref11","doi-asserted-by":"crossref","unstructured":"Keam B, Machiels JP, Kim HR, et al. Pan-Asian adaptation of the EHNS-ESMO-ESTRO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with squamous cell carcinoma of the head and neck. ESMO Open 2021;6:100309. httpss:\/\/doi.org\/10.1016\/j.esmoop.2021.100309","DOI":"10.1016\/j.esmoop.2021.100309"},{"key":"10.14639\/0392-100X-A1264_ref12","unstructured":"National Comprehensive Cancer Network. NCCN guidelines: head and neck cancers. [Internet]. Plymouth (UK), [Version 2.2023]. Available from: httpss:\/\/www.nccn.org\/guidelines\/category_1, cited: November 30, 2023."},{"key":"10.14639\/0392-100X-A1264_ref13","doi-asserted-by":"crossref","unstructured":"H\u00f8xbroe Michaelsen S, Gr\u00f8nh\u00f8j C, H\u00f8xbroe Michaelsen J, et al. Quality of life in survivors of oropharyngeal cancer: a systematic review and meta-analysis of 1366 patients. Eur J Cancer 2017;78:91-102. httpss:\/\/doi.org\/10.1016\/j.ejca.2017.03.006","DOI":"10.1016\/j.ejca.2017.03.006"},{"key":"10.14639\/0392-100X-A1264_ref14","doi-asserted-by":"crossref","unstructured":"Roets E, Tukanova K, Govarts A, et al. Quality of life in oropharyngeal cancer: a structured review of the literature. Supportive Care Cancer 2018;26:2511-2518. https:\/\/doi.org\/10.1007\/s00520-018-4227-9","DOI":"10.1007\/s00520-018-4227-9"},{"key":"10.14639\/0392-100X-A1264_ref15","doi-asserted-by":"crossref","unstructured":"Jensen SB, Vissink A, Limesand KH, et al. Salivary gland hypofunction and xerostomia in head and neck radiation patients. J Natl Cancer Inst Monogr 2019;2019:lgz016. https:\/\/doi.org\/10.1093\/jncimonographs\/lgz016","DOI":"10.1093\/jncimonographs\/lgz016"},{"key":"10.14639\/0392-100X-A1264_ref16","doi-asserted-by":"crossref","unstructured":"Vissink A, Jansma J, Spijkervet FKL, et al. Oral sequelae of head and neck radiotherapy. Crit Rev Oral Biol Med 2003;14:199-212. https:\/\/doi.org\/10.1177\/154411130301400305","DOI":"10.1177\/154411130301400305"},{"key":"10.14639\/0392-100X-A1264_ref17","doi-asserted-by":"crossref","unstructured":"Larsen MHH, Kehlet H, von Buchwald C. Transoral robotic surgery \u2013 Time for consensus on pain assessment. A review. Acta Otolaryngol 2023;143:902-911. https:\/\/doi.org\/10.1080\/00016489.2023.2282149","DOI":"10.1080\/00016489.2023.2282149"},{"key":"10.14639\/0392-100X-A1264_ref18","doi-asserted-by":"crossref","unstructured":"Larsen MHH, Scott SI, Kehlet H, et al. Days alive and out of hospital a validated patient-centred outcome to be used for patients undergoing transoral robotic surgery: protocol and perspectives. Acta Otolaryngol 2021;141:95-98. https:\/\/doi.org\/10.1080\/00016489.2020.1814964","DOI":"10.1080\/00016489.2020.1814964"},{"key":"10.14639\/0392-100X-A1264_ref19","doi-asserted-by":"crossref","unstructured":"Togni L, Mascitti M, Vignigni A, et al. Treatment-related dysgeusia in oral and oropharyngeal cancer: a comprehensive review. Nutrients 2021;13:3325. https:\/\/doi.org\/10.3390\/nu13103325","DOI":"10.3390\/nu13103325"},{"key":"10.14639\/0392-100X-A1264_ref20","doi-asserted-by":"crossref","unstructured":"Casswell G, Gough K, Drosdowsky A, et al. Sexual health and interpersonal relationships after chemoradiation therapy for human papillomavirus-associated oropharyngeal cancer: a cross-sectional study. Int J Radiat Oncol Biol Phys 2021;110:382-393. https:\/\/doi.org\/10.1016\/j.ijrobp.2020.11.005","DOI":"10.1016\/j.ijrobp.2020.11.005"},{"key":"10.14639\/0392-100X-A1264_ref21","doi-asserted-by":"crossref","unstructured":"Lansner MW, Jakobsen KK, Jensen JS, et al. Development of depression in patients with oral cavity cancer: a systematic review. Acta Otolaryngol 2020;140:876-881. https:\/\/doi.org\/10.1080\/00016489.2020.1778785","DOI":"10.1080\/00016489.2020.1778785"},{"key":"10.14639\/0392-100X-A1264_ref22","doi-asserted-by":"crossref","unstructured":"Hartung TJ, Br\u00e4hler E, Faller H, et al. The risk of being depressed is significantly higher in cancer patients than in the general population: prevalence and severity of depressive symptoms across major cancer types. Eur J Cancer 2017;72:46-53. https:\/\/doi.org\/10.1016\/j.ejca.2016.11.017","DOI":"10.1016\/j.ejca.2016.11.017"},{"key":"10.14639\/0392-100X-A1264_ref23","doi-asserted-by":"crossref","unstructured":"Massie MJ. Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr 2004;2004:57-71. https:\/\/doi.org\/10.1093\/jncimonographs\/lgh014","DOI":"10.1093\/jncimonographs\/lgh014"},{"key":"10.14639\/0392-100X-A1264_ref24","doi-asserted-by":"crossref","unstructured":"Satin JR, Linden W, Phillips MJ. Depression as a predictor of disease progression and mortality in cancer patients: a meta-analysis. Cancer 2009;115. https:\/\/doi.org\/10.1002\/cncr.24561","DOI":"10.1002\/cncr.24561"},{"key":"10.14639\/0392-100X-A1264_ref25","doi-asserted-by":"crossref","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. The BMJ 2021;372:N71. https:\/\/doi.org\/10.1136\/bmj.n71","DOI":"10.1136\/bmj.n71"},{"key":"10.14639\/0392-100X-A1264_ref26","doi-asserted-by":"crossref","unstructured":"Jansen F, Verdonck-de Leeuw IM, Cuijpers P, et al. Depressive symptoms in relation to overall survival in people with head and neck cancer: a longitudinal cohort study. Psychooncology 2018;27:2245-2256. https:\/\/doi.org\/10.1002\/pon.4816","DOI":"10.1002\/pon.4816"},{"key":"10.14639\/0392-100X-A1264_ref27","doi-asserted-by":"crossref","unstructured":"Shinn EH, Valentine A, Jethanandani A, et al. Depression and oropharynx cancer outcome. Psychosom Med 2016;78:38-48. https:\/\/doi.org\/10.1097\/PSY.0000000000000256","DOI":"10.1097\/PSY.0000000000000256"},{"key":"10.14639\/0392-100X-A1264_ref28","doi-asserted-by":"crossref","unstructured":"Bigelow EO, Blackford AL, Eytan DF, et al. Burden of comorbidities is higher among elderly survivors of oropharyngeal cancer compared with controls. Cancer 2020;126:1793-1803. https:\/\/doi.org\/10.1002\/cncr.32703","DOI":"10.1002\/cncr.32703"},{"key":"10.14639\/0392-100X-A1264_ref29","doi-asserted-by":"crossref","unstructured":"McDowell L, Casswell G, Bressel M, et al. Symptom burden, quality of life, functioning and emotional distress in survivors of human papillomavirus associated oropharyngeal cancer: an Australian cohort. Oral Oncol 2021;122:105560. https:\/\/doi.org\/10.1016\/j.oraloncology.2021.105560","DOI":"10.1016\/j.oraloncology.2021.105560"},{"key":"10.14639\/0392-100X-A1264_ref30","doi-asserted-by":"crossref","unstructured":"Hinz A, Mehnert A, Kocalevent RD, et al. Assessment of depression severity with the PHQ-9 in cancer patients and in the general population. BMC Psychiatry 2016;16:22. https:\/\/doi.org\/10.1186\/s12888-016-0728-6","DOI":"10.1186\/s12888-016-0728-6"},{"key":"10.14639\/0392-100X-A1264_ref31","doi-asserted-by":"crossref","unstructured":"Clover K, Lambert SD, Oldmeadow C, et al. PROMIS depression measures perform similarly to legacy measures relative to a structured diagnostic interview for depression in cancer patients. Qual Life Res 2018;27:1357-1367. https:\/\/doi.org\/10.1007\/s11136-018-1803-x","DOI":"10.1007\/s11136-018-1803-x"},{"key":"10.14639\/0392-100X-A1264_ref32","doi-asserted-by":"crossref","unstructured":"Kroenke K, Stump TE, Kean J, et al. Diagnostic operating characteristics of PROMIS scales in screening for depression. J Psychosom Res 2021;147:110532. https:\/\/doi.org\/10.1016\/j.jpsychores.2021.110532","DOI":"10.1016\/j.jpsychores.2021.110532"},{"key":"10.14639\/0392-100X-A1264_ref33","doi-asserted-by":"crossref","unstructured":"Kroenke K, Spitzer RL, Williams JBW. The PHQ-9. J Gen Intern Med 2001;16:606-613. https:\/\/doi.org\/10.1046\/j.1525-1497.2001.016009606.x","DOI":"10.1046\/j.1525-1497.2001.016009606.x"},{"key":"10.14639\/0392-100X-A1264_ref34","doi-asserted-by":"crossref","unstructured":"Smith HR. Depression in cancer patients: pathogenesis, implications and treatment (review). Oncol Lett 2015;9:1509-1514. https:\/\/doi.org\/10.3892\/ol.2015.2944","DOI":"10.3892\/ol.2015.2944"},{"key":"10.14639\/0392-100X-A1264_ref35","doi-asserted-by":"crossref","unstructured":"Boden JM, Fergusson DM. Alcohol and depression. Addiction 2011;106:906-914. https:\/\/doi.org\/10.1111\/j.1360-0443.2010.03351.x","DOI":"10.1111\/j.1360-0443.2010.03351.x"},{"key":"10.14639\/0392-100X-A1264_ref36","doi-asserted-by":"crossref","unstructured":"Zamani M, Gr\u00f8nh\u00f8j C, Jensen DH, et al. The current epidemic of HPV-associated oropharyngeal cancer: an 18-year Danish population-based study with 2,169 patients. Eur J Cancer 2020;134:52-59. https:\/\/doi.org\/10.1016\/j.ejca.2020.04.027","DOI":"10.1016\/j.ejca.2020.04.027"},{"key":"10.14639\/0392-100X-A1264_ref37","doi-asserted-by":"crossref","unstructured":"Bouvard V, Baan R, Straif K, et al. A review of human carcinogens \u2013 Part B: biological agents. Lancet Oncol 2009;10:321-322. https:\/\/doi.org\/10.1016\/s1470-2045(09)70096-8","DOI":"10.1016\/S1470-2045(09)70096-8"},{"key":"10.14639\/0392-100X-A1264_ref38","doi-asserted-by":"crossref","unstructured":"Jan\u00e9-Llopis E, Matytsina I. Mental health and alcohol, drugs and tobacco: a review of the comorbidity between mental disorders and the use of alcohol, tobacco and illicit drugs. Drug Alcohol Rev 2006;25:515-536. https:\/\/doi.org\/10.1080\/09595230600944461","DOI":"10.1080\/09595230600944461"},{"key":"10.14639\/0392-100X-A1264_ref39","doi-asserted-by":"crossref","unstructured":"Glassman AH, Covey LS, Stetner F, et al. Smoking cessation and the course of major depression: a follow-up study. Lancet 2001;357:1929-1932. https:\/\/doi.org\/10.1016\/S0140-6736(00)05064-9","DOI":"10.1016\/S0140-6736(00)05064-9"},{"key":"10.14639\/0392-100X-A1264_ref40","doi-asserted-by":"crossref","unstructured":"Rieke K, Schmid KK, Lydiatt W, et al. Depression and survival in head and neck cancer patients. Oral Oncol 2017;65:76-82. https:\/\/doi.org\/10.1016\/j.oraloncology.2016.12.014","DOI":"10.1016\/j.oraloncology.2016.12.014"},{"key":"10.14639\/0392-100X-A1264_ref41","doi-asserted-by":"crossref","unstructured":"Mitchell AJ, Meader N, Symonds P. Diagnostic validity of the Hospital Anxiety and Depression Scale (HADS) in cancer and palliative settings: a meta-analysis. J Affect Disord 2010;126:335-348. https:\/\/doi.org\/10.1016\/j.jad.2010.01.067","DOI":"10.1016\/j.jad.2010.01.067"},{"key":"10.14639\/0392-100X-A1264_ref42","doi-asserted-by":"crossref","unstructured":"Cai H, Jin Y, Liu R, et al. Global prevalence of depression in older adults: a systematic review and meta-analysis of epidemiological surveys. Asian J Psychiatr 2023;80:103417. https:\/\/doi.org\/10.1016\/j.ajp.2022.103417","DOI":"10.1016\/j.ajp.2022.103417"},{"key":"10.14639\/0392-100X-A1264_ref43","doi-asserted-by":"crossref","unstructured":"Blazer DG. Depression in late life: review and commentary. J Gerontol A Biol Sci Med Sci 2003;58:249-265. https:\/\/doi.org\/10.1093\/gerona\/58.3.m249","DOI":"10.1093\/gerona\/58.3.M249"},{"key":"10.14639\/0392-100X-A1264_ref44","doi-asserted-by":"crossref","unstructured":"Hasin DS, Goodwin RD, Stinson FS, et al. Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcoholism and Related Conditions. Arch Gen Psychiatry 2005;62:1097-1106. https:\/\/doi.org\/10.1001\/archpsyc.62.10.1097","DOI":"10.1001\/archpsyc.62.10.1097"},{"key":"10.14639\/0392-100X-A1264_ref45","doi-asserted-by":"crossref","unstructured":"Djernes JK. Prevalence and predictors of depression in populations of elderly: a review. Acta Psychiatr Scand 2006;113:372-387. https:\/\/doi.org\/10.1111\/j.1600-0447.2006.00770.x","DOI":"10.1111\/j.1600-0447.2006.00770.x"},{"key":"10.14639\/0392-100X-A1264_ref46","doi-asserted-by":"crossref","unstructured":"Hvidberg MF, Johnsen SP, Davidsen M, et al. A nationwide study of prevalence rates and characteristics of 199 chronic conditions in Denmark. Pharmacoecon Open 2020;4:361-380. https:\/\/doi.org\/10.1007\/s41669-019-0167-7","DOI":"10.1007\/s41669-019-0167-7"},{"key":"10.14639\/0392-100X-A1264_ref47","unstructured":"Mairey I, Rosenkilde S, Borring Klitgaard M, et al. Statens Institut for Folkesundhed, Syddansk Universitet. Sygdomsbyrden i Danmark \u2013 Sygdomme. K\u00f8benhavn: Sundhedsstyrelsen; 2022."}],"container-title":["Acta Otorhinolaryngologica Italica"],"original-title":[],"link":[{"URL":"https:\/\/www.actaitalica.it\/article\/view\/1264","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T08:26:56Z","timestamp":1782116816000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.actaitalica.it\/article\/view\/1264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":47,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,6]]}},"URL":"https:\/\/doi.org\/10.14639\/0392-100x-a1264","relation":{},"ISSN":["1827-675X"],"issn-type":[{"value":"1827-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]},"article-number":"1"}}